Sponsor:
Senti Biosciences
Code:
NCT06325748
Conditions
AML/MDS
CD33 Expressing Hematological Malignancies
FLT3 Expressing Hematological Malignancies
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
SENTI-202
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations